Interest in combination drug therapy is rapidly growing due to the opportunities they create to increase the efficacy of the therapeutic effect, to combat drug resistance and to reduce the magnitude of undesirable side effects. Drug combinations studies are widely used and became the leading choice for drug discovery in oncology and immunology therapeutic areas.

BioMedha offers analysis of test agents (dose response matrix) to measure Synergism, or Antagonism effect in the following assay formats:

  • Cytotoxicity assays using disease relevant cell models
  • T cell activation assays: proliferation and cytokines levels
  • Project-specific functional/ expression end-point assays